For the third year in a row, government negotiators for 12 Pacific Rim countries have missed an internal deadline to reach agreement on a controversial U.S.-led trade deal.
Formal negotiations began this week around the increasingly significant global trade in “environmental goods”, those technologies seen as environmentally beneficial, including in combating climate change.
The Trans Pacific Partnership Agreement (TPP), the negotiation of which is set to conclude this year, could drive research into new drugs and improve access to medicines. Except – it won’t.